Allovir

AlloVir develops cell therapies focused on restoring immunity against virus-associated diseases in patients with severely weakened immune systems.

Biotechnology Research

Explore the company ↓Explore its lists ↓

Headquarters: Waltham, Massachusetts, United StatesSource: RevenueBaseRetrieved October 13, 2026
Employee range: 51 to 200Source: RevenueBaseRetrieved October 13, 2026
Published list appearances: 4 supported appearances ↗Source: RevenueBase lists

The company at a glance

What does Allovir do?

Its platforms use off-the-shelf, allogeneic, multi-virus-specific T cells targeting viral pathogens in immunocompromised patients. Each allogeneic cell therapy has the potential to treat and/or prevent up to six viruses.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

What the business offers

Services & capabilities.

Cell therapies

Develops therapies focused on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

Source: LinkedIn company description · Retrieved October 13, 2026

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

#16OF 23

Waltham

Immunotherapy developers

Snapshot: September 19, 2026

↗

#18OF 25

United States

Immunodeficiency syndromes gene therapy companies

Snapshot: September 18, 2026

↗

#20OF 25

United States

Oncolytic virus therapy companies

Snapshot: September 19, 2026

↗

#24OF 25

United States

Therapeutic virology companies

Snapshot: September 21, 2026

↗

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEW

Open the published source list.

Allovir

#16 Immunotherapy developers

Snapshot: September 19, 2026

Display size

Download SVG

Copy this code into your website

<a href="https://revenuebase.ai/companies/immunotherapy-developers/united-states/waltham" target="_blank" rel="nofollow noopener">
  <img src="https://revenuebase.ai/companies/profiles/allovir/recognition-companies-immunotherapy-developers-united-states-waltham-20260920-00cd5d2eda14fa3dc8065aa00121d6f622c9c24e1ff6d04add04a554ce13712a.svg" alt="Allovir listed #16 on Immunotherapy developers, September 19, 2026" width="220" height="319" style="max-width:100%;height:auto;" />
</a>

View live list ↗

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026, September 19, 2026 and September 21, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →